We only have this paper's title and publication details.
Read it at the sourceExperimental evaluation reveals that Syk inhibition reprograms tumor-associated macrophages in pancreatic ductal adenocarcinoma, indicating reversed gemcitabine-induced immunosuppression.
Supplementary methods and Legends to supplementary figures
No takes yet. Share an insight, caveat, or question.
Rohila et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: